Skip to content

Engineering Solution & Consultancy

The four phases of a technology transfer

  • Engineering Solution & Consultancy
  • 1 min read

Two phases of a technology transfer should already be done by the time the first trial batch runs.

WHO Technical Report Series 1044 (2022), Annex 4, says a technology transfer project plan may be divided into phases, and names four. A sending unit (SU) hands over; a receiving unit (RU) takes on.

  1. Initiate: establish why the transfer is needed and whether the RU has the expertise, technology and capability to take it.
  2. Plan: the marketing authorisation holder, SU and RU should jointly set up a team. It should perform a gap analysis and risk assessment, write the transfer protocol and develop the control strategy. The SU should provide the process knowledge and its history.
  3. Execute: analytical procedures should be in place at the testing laboratory before process validation samples are tested. Cleaning procedures should be designed at the RU, for its own equipment.
  4. Review and close out: a transfer report should carry a conclusion, authorised by the responsible person, stating whether the transfer was completed.

A project that opens with the trial batch has skipped the first two. When that batch fails, nobody can say whether the cause is the process, an equipment difference a gap analysis would have listed, or an assay method that was never transferred.

Technology transfer is part of Humiley's EU-GMP roadmap consulting, alongside QMS and the CTD/eCTD dossier.

Industries

Related

More on this subject

The VMP item inspectors read first

EU GMP Annex 15 (2015) lists seven elements a validation master plan should cover. The summary of facilities and systems with their qualification status is the one inspectors use: last qualification, next requalification and open deviations, in one table rather than a paragraph of intent.

InsightRead

EU GMP Annex 15 (2015) treats three consecutive PPQ batches as a common minimum, with the number justified from risk; the FDA's 2011 guidance names no count and works in three stages. A rationale that serves both draws on commercial-scale variability, parameters near their proven limits, prior knowledge and a statistical target on the CQAs.

InsightRead

Transport verification lives in Annex 15

EU GMP Annex 15 asks for transport of finished products, investigational products and samples to be verified per route, seasons included. The plan is usually sound; the gap is the logger nobody checks before release. Name one role that downloads each logger on time, checks it against limits and can hold the stock.

InsightRead